Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a frequent indication for lung transplantation (LTX) with pulmonary hypertension (PH) negatively affecting outcome. The optimal procedure type remains a debated topic. The aim of this study was to evaluate the impact of pretransplant PH in IPF patients. Single LTX (SLTX, n = 46) was the standard procedure type. Double LTX (DLTX, n = 30) was only performed in cases of relevant PH or additional suppurative lung disease. There was no significant difference for pretransplant clinical parameters. Preoperative mean pulmonary arterial pressure was significantly higher in DLTX recipients (22.7 +/- 0.8 mmHg vs. 35.9 +/- 1.8 mmHg, P < 0.001). After transplantation, 6-min-walk distance and BEST-FEV(1) were significantly higher for DLTX patients (6-MWD: 410 +/- 25 m vs. 498 +/- 23 m, P = 0.02; BEST-FEV(1): 71.2 +/- 3.0 (% pred) vs. 86.2 +/- 4.2 (% pred), P = 0.004). Double LTX recipients demonstrated a significantly better 1-year-, overall- and Bronchiolitis obliterans Syndrome (BOS)-free survival (P < 0.05). Cox regression analysis confirmed SLTX to be a significant predictor for death and BOS. Single LTX offers acceptable survival rates for IPF patients. Double LTX provides a significant benefit in selected recipients. Our data warrant further trials of SLTX versus DLTX stratifying for potential confounders including PH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
Risk factors for early primary graft dysfunction after lung transplantation: a registry study
Kuntz, C. L., Hadjiliadis, D., Ahya, V. N., Kotloff, R. M., Pochettino, A., Lewis, J., & Christie, J. D. (2009) · Clinical Transplantation · doi:10.1111/j.1399-0012.2008.00951.x · Cited by 138 · cited 1×
“Some studies have identified preoperative PH in IPF patients receiving SLTX to be associated with an increased risk of early primary graft dysfunction, prolonged intensive care unit stay and higher 90-day-mortality [10–12].”
Background
Cited by
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Self-citationLung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
Kistler, K. D., Nalysnyk, L., Rotella, P., & Esser, D. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-139 · Cited by 151
Force, S. D., Kilgo, P., Neujahr, D. C., Pelaez, A., Pickens, A., Fernandez, F. G., Miller, D. L., & Lawrence, C. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.08.055 · Cited by 69
“The Munich Lung Transplant Group [16] found a significant increase in BOS-free survival in patients undergoing BLT for IPF compared with SLT patients.”
Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
Leuschner, G., Stocker, F., Veit, T., Kneidinger, N., Winter, H., Schramm, R., Weig, T., Matthes, S., Ceelen, F., Arnold, P., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.002 · Cited by 59
Self-citationHayes, D., Higgins, R. S., Black, S. M., Wehr, A. M., Lehman, A. M., Kirkby, S., & Whitson, B. A. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.004 · Cited by 41
Metadata
- Authors
- Neurohr, C., Huppmann, P., Thum, D., Leuschner, W., von Wulffen, W., Meis, T., Leuchte, H., Baumgartner, R., Zimmermann, G., Hatz, R., Czerner, S., Frey, L., Ueberfuhr, P., Bittmann, I., Behr, J., & for the Munich Lung Transplant Group
- Venue
- Transplant International
- Publisher
- Frontiers Media SA
- Published
- 2010-03
- Volume
- 23
- Issue
- 9
- Pages
- 887-96
- ISSN
- 0934-0874 (ISSN-L)
- 1432-2277
- OpenAlex
- W1980747382
- Cited by
- 64
- References
- 3
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1111/j.1432-2277.2010.01071.x
- The paper
- Neurohr, C., Huppmann, P., Thum, D., Leuschner, W., von Wulffen, W., Meis, T., Leuchte, H., Baumgartner, R., Zimmermann, G., Hatz, R., Czerner, S., Frey, L., Ueberfuhr, P., Bittmann, I., Behr, J., & for the Munich Lung Transplant Group. (2010). Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis. Transplant International. https://doi.org/10.1111/j.1432-2277.2010.01071.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.